Presentation TCT 2017 US Trial Background and Update: Preserve-AMI Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry October 31, 2017
Presentation TCT 2017 Malaysia Comments to Kuwait: How I Would Manage This Case Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Amin Ariff Nuruddin October 31, 2017
Presentation TCT 2017 Establishing a Safety Culture in the Cath Lab Presenter: Robert J. Applegate, Daniel M. Kolansky, Arnold Seto October 31, 2017
Presentation TCT 2017 Kuwait Presents to Malaysia: A Complex Coronary Case Presenter: Mohammad Al-Mutairi, Ahmed Magdy October 31, 2017
Presentation TCT 2017 FDA Perspectives on Short DAPT IDE Trials Presenter: Mitchell W. Krucoff, P.F. Adrian Magee October 31, 2017
Presentation TCT 2017 TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu October 31, 2017
Presentation TCT 2017 The Clinical Point of View: Is There an AMI Need for Cell Therapy? Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez October 31, 2017
Presentation TCT 2017 The Role and Responsibilities of the Cath Lab Manager Presenter: Robert J. Applegate, Daniel M. Kolansky, Bernadette S. Speiser October 31, 2017
Presentation TCT 2017 TCT 46: Prevalence of Thin-Cap Fibroatheroma and Plaque Rupture in Fractional Flow Reserve Negative Lesions in Diabetic Patients With or Without Acute Coronary Syndrome - Insights from the COMBINE Study Presenter: John McB. Hodgson, Akiko Maehara, Balazs Berta, MD October 31, 2017
Presentation TCT 2017 TCT 102: Five-Year Outcomes of Left Atrial Appendage Closure: Final Results of the Continued Access to PROTECT AF (CAP) Registry Presenter: Brij Maini, Petr Neuzil, David R. Holmes Jr. October 31, 2017